You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 17, November 2, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Cardiovascular System
 •Arrhythmias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fish Oil Supplementation and Arrhythmias—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Drs Strauss, Dorian, and Verma that our finding of a trend toward an increased risk of ventricular arrhythmias in patients with ICDs assigned to fish oil must be put into context. The GISSI trial1 and other studies in patients with recent myocardial infarction provide good evidence that in this group fish oil supplementation reduces mortality and that this is likely due to the suppression of ischemic VF.

Because ICDs are not usually implanted in patients who have had ischemic VF, our results are more likely due to an adverse effect of fish oil on scar-based reentry. An important question is what effect fish oil supplementation has in patients with coronary artery disease who have had neither a recent myocardial infarction nor an arrhythmia leading to ICD implantation. The American Heart Association has indeed recommended that physicians consider omega-3 supplements in all patients with documented coronary . . . [Full Text of this Article]

Merritt Raitt, MD
merritt.raitt@med.va.gov
Portland VA Medical Center
Portland, Ore

William E. Connor, MD; Cynthia Morris, PhD, MPH; John McAnulty, MD
Oregon Health and Science University
Portland, Ore



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Fish Oil Supplementation and Arrhythmias
Martin H. Strauss, Paul Dorian, and Subodh Verma
JAMA. 2005;294(17):2165.
EXTRACT | FULL TEXT  

Fish Oil Supplementation and Risk of Ventricular Tachycardia and Ventricular Fibrillation in Patients With Implantable Defibrillators: A Randomized Controlled Trial
Merritt H. Raitt, William E. Connor, Cynthia Morris, Jack Kron, Blair Halperin, Sumeet S. Chugh, James McClelland, James Cook, Karen MacMurdy, Robert Swenson, Sonja L. Connor, Glenn Gerhard, Dale F. Kraemer, Daniel Oseran, Christy Marchant, David Calhoun, Reed Shnider, and John McAnulty
JAMA. 2005;293(23):2884-2891.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.